Target intelligence / Profile preview

Stromal cell-derived factor 2 (SDF2)

Target
SDF2
Molecular classification
Other (ER-resident protein), Protein-folding chaperone cofactor, Secretory protein
01

Overview

Stromal cell-derived factor 2 (SDF2) is a conserved, ubiquitously expressed protein localized mainly in the endoplasmic reticulum (ER), where it functions as a regulatory cofactor involved in protein folding and the unfolded protein response (UPR)[1][2][3][4][5]. Unlike SDF1/CXCL12 and other stromal cell-derived factors, SDF2 is not a chemokine or receptor, but rather an ER-resident protein associated with protein folding and cellular stress adaptation[1][2][4]. SDF2 expression is altered in cancer, placental disorders, and other disease contexts linked to ER stress, making it a candidate biomarker for certain conditions but not a direct druggable target[2][4][5]. Critical notes: - SDF2 should not be confused with "SDF-1" (CXCL12), a chemokine/receptor widely targeted in drug discovery. - The name "stromal cell derived factor 2" is correct for this protein; however, its function is regulatory in ER homeostasis, *not as a receptor or chemokine*. - SDF2's therapeutic and biomarker potential is still being explored, especially for ER stress-related pathologies[1][2].

Other names
SDF2Stromal cell derived factor 2Stromal cell-derived factor 2SDF-2
02

Biological functions

Regulation of the unfolded protein response (UPR) in the endoplasmic reticulumProtein folding homeostasisRegulation of cell survival and apoptosis under ER stress
03

Disease associations

Cancer (expression reduced in advanced/metastatic breast and colorectal cancer, poor prognosis)Pregnancy-related diseases (e.g., preeclampsia, intrauterine growth restriction, placental dysfunction)Diabetes (linked to chronic ER stress)Other (possibly involved in developmental regulation)
04

Biomarkers

Altered SDF2 expression can serve as a biomarker for ER stress regulatory status, placental function, and poor prognosis in cancerDownregulation correlates with cell survival profile under ER stress

Beyond the preview

Go deeper on Stromal cell-derived factor 2 (SDF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stromal cell-derived factor 2 (SDF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call